14th Annual Scottsdale Prostate Cancer Symposium 2009 March 5-8, 2009 Camelback Inn, A JW Marriott Resort and Spa Scottsdale, Arizona

Target Audience This course is intended for urologists, radiation oncologists, radiologists, medical oncologists, pathologists, physicians, dosimetrists, and nurses. It will educate the registrants about advances in management of localized and advanced prostate cancer. . Course Objectives At the conclusion of this activity, participants will be able to: • Describe the new techniques of real-time, dose-moderated brachytherapy, robotic prostatectomy, and high intensity focused ultrasound (HiFu). • Identify appropriate patients for brachytherapy IMRT/IGRT, robotic and open prostatectomy, HiFu and salvage therapies. • Explain potential benefits of chemotherapy in patients with locally advanced and hormone refractory prostate cancer. • Identify the role of bisphosphonates in advanced prostate cancer. • Define the role of metabolic syndrome in patients in androgen withdrawal. • Review the use of nutritional supplements (nutricals) in men with prostate cancer.   Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Diversified Conference Management, Inc. (DCMI). PIM is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this educational activity for a maximum of 18.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. . Jointly Sponsored by Postgraduate Institute for Medicine and Diversified Conference Management, Inc.   Educational Grant Supporter: Sanofi- Aventis   Exhibitors: Aureon Laboratories Bard Urological Best Medical International, Inc. Brachysciences CMS, Inc. Indevus Pharmaceutical NAS Medical   This activity is supported by multiple educational grants.   Home | About Us | Contact Prostate | Faculty | Agenda | Information | Exhibit Application | Hotel | Registration   Copyright ©2001. All Rights Reserved. Last Revised 1-26-09